Terumo Corporation Partners with MedHub-AI to Market AI-Based FFR Technology in Japan

Terumo Corporation, a leading manufacturer of health care equipment and supply, has entered into a partnership with MedHub-AI to market AI-based Fractional Flow Reserve (FFR) technology in Japan.

Key Highlights of the Partnership

• Terumo Corporation will collaborate with MedHub-AI to market AI-based FFR technology in Japan.
• The partnership aims to bring advancements in coronary physiology assessment, offering improved confidence and clinical accuracy compared to conventional methods.

Market Impact

• The partnership is expected to have a positive impact on Terumo Corporation’s prospects, reflected in a moderate price increase of the company’s shares.
• The patient temperature monitoring market, in which Terumo operates through its electronic thermometer products, is expected to experience substantial growth driven by factors such as:
  • A growing global population
  • Increased awareness of infectious diseases

Market Growth Drivers

• The patient temperature monitoring market is expected to experience substantial growth, driven by factors such as:
  • A growing global population
  • Increased awareness of infectious diseases
• This growth is expected to have a positive impact on Terumo Corporation’s business prospects.